Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?
- PMID: 19398567
- DOI: 10.1200/JCO.2009.22.3305
Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?
Comment on
-
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.J Clin Oncol. 2009 Feb 1;27(4):591-8. doi: 10.1200/JCO.2008.17.1405. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075278 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical